HopeStage
Back to all studies
CompletedNCT00134459

Bifeprunox for depression in bipolarity

About this title

Study Evaluating Bifeprunox in Bipolar Depression

Read the official source — NCT00134459
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Birmingham and 39 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2005
Recruitment status
Completed
Enrollment listed in the registry
434
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00134459
Official title
Show the full official title

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-Group Study of Bifeprunox in the Treatment of Depression in Outpatients With Bipolar Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham · Beverly Hills · National City

35 more locations
  • Stanford
  • Farmington Hills
  • Bradenton
  • Jacksonville
  • Orlando
  • West Palm Beach
  • Smyrna
  • Honolulu
  • Terre Haute
  • Florence
  • New Orleans
  • Rockville
  • Boston
  • Saint Charles
  • Clementon
  • Moorestown
  • Lawrence
  • New York
  • Staten Island
  • The Bronx
  • Winston-Salem
  • Cincinnati
  • Dayton
  • Lyndhurst
  • Oklahoma City
  • Tulsa
  • Portland
  • Philadelphia
  • Charleston
  • Austin
  • Dallas
  • Salt Lake City
  • Bellevue
  • Seattle
  • Brown Deer

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Wyeth is now a wholly owned subsidiary of Pfizer.

Did this study involve medication?

Yes. The study involved medication, including Bifeprunox and Placebo.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies